ArticlePDF Available

Basal cell nevus syndrome in a 56-year old Filipino female: a case report

Authors:

Abstract and Figures

Introduction:Basal cell nevus syndrome (BCNS) (Gorlin-Goltz syndrome or Nevoid basal cell carcinoma syndrome) is a rare inherited multisystem and tumor-predisposing disorder caused by the patched tumor suppressor gene mutations and suppressor of fused gene. Its diagnosis follows a set of criteria based on specific cutaneous features and radiologic findings. Although an autosomal dominant disorder with a high degree of penetrance is the usual mode of transmission, BCNS has variable phenotypic expression making its diagnosis difficult. The limited epidemiologic data among Asians especially in the Philippines hamper early detection or cause frequent misdiagnosis of the condition. Case report: A 56-year-old Filipino female with Fitzpatrick skin type V presents with early onset multiple basal cell carcinomas and bilateral palmoplantar pits. Radiologic investigation reveals odontogenic keratocyst, calcification of the falx cerebri, bridging of the sella turcica, bifid/splayed ribs and vertebral anomalies. The patient exhibits coarse facial features and bilateral cataract. Cranial computed tomography scan shows cerebrocerebellar atrophy with ventricular dilatation. Management included wide excision of the nodular basal cell carcinomas (BCC), application of 5-flourouracil cream on the superficial BCC and electrodessication and curettage of the smaller lesions. Oral acitretin was also prescribed. Conclusion:This is a case that highlights the approach to diagnosis, clinical features and management of BCNS in a Filipino patient. Since various phenotypic presentations may exist among dark-skinned individuals, early diagnosis poses a challenge among physicians. Epidemiologic and prevalence studies among Filipinos may be done to aid in the diagnosis and early management of this rare genodermatosis.
Content may be subject to copyright.
CASE REPORT
Basal cell nevus syndrome in a 56-year old Filipino
female: a case report
Kathleen May V. Eusebio-Alpapara, MD, DPDS1, Cindy Pearl Sotalbo, MD, FPCR2, Cynthia Ciriaco-Tan,
MD, FPDS1
Introduction: Basal cell nevus syndrome (BCNS) (Gorlin-Goltz syndrome or Nevoid basal cell carcinoma syndrome) is a rare
inherited multisystem and tumor-predisposing disorder caused by the patched tumor suppressor gene mutations and
suppressor of fused gene. Its diagnosis follows a set of criteria based on specific cutaneous features and radiologic findings.
Although an autosomal dominant disorder with a high degree of penetrance, BCNS has variable expression making its
diagnosis difficult. The limited epidemiologic data among Asians especially in the Philippines hamper early detection or
cause frequent misdiagnosis of the condition.
Case report: A 56-year-old Filipino female with Fitzpatrick skin type V presented with early onset multiple basal cell
carcinomas and bilateral palmoplantar pits. Radiologic investigation reveals odontogenic keratocyst, calcification of the
falx cerebri, bridging of the sella turcica, bifid/splayed ribs and vertebral anomalies. The patient exhibits coarse facial
features and bilateral cataracts. Cranial computed tomography scan shows cerebrocerebellar atrophy with ventricular
dilatation. Management included wide excision of the nodular basal cell carcinomas (BCC), application of 5-flourouracil
cream on the superficial BCC and electrodessication and curettage of the smaller lesions. Oral acitretin was also prescribed.
Conclusion: This is a case that highlights the approach to diagnosis, clinical features and management of BCNS in a Filipino
patient. Since various phenotypic presentations may exist among dark-skinned individuals, early diagnosis poses a challenge
among physicians. Epidemiologic and prevalence studies among Filipinos may be done to aid in the diagnosis and early
management of this rare genodermatosis.
Keywords: Basal cell nevus syndrome, Gorlin-Goltz syndrome, Nevoid basal cell carcinoma syndrome, Basal Cell Carcinoma
INTRODUCTION
Basal cell nevus syndrome (BCNS) (Gorlin-Goltz syndrome
or Nevoid basal cell carcinoma syndrome) is a rare
inherited multisystem and tumor-predisposing disorder
caused by the patched
__________________________________________
1Section of Dermatology, Department of internal medicine, University
of the Philippines-Philippine General Hospital
2Department of Radiology, University of the Philippines-Philippine
General Hospital
Source of funding: none
Conflict of interest: none
Corresponding author:
Kathleen May V. Eusebio-Alpapara, MD, DPDS
tumor suppressor gene (PTCH1) mutations, in most cases,
and suppressor of fused (SUFU) gene. Diagnosis follows a
set of criteria based on specific cutaneous features and
radiologic findings. (Table 1) A patient must fulfill either
two major criteria or 1 major and 1 minor criterion to
make the diagnosis of BCNS.2, 3,4
42 J Phil Dermatol Soc · May 2019 · ISSN 2094-201X
Table 1. Criteria for the diagnosis of Basal Cell Nevus Syndrome 2,3,5
Major:
Calcification of the falx cerebri
Odontogenic keratocyst
2 or more palmoplantar pits
Multiple basal cell carcinomas, BCCs (>5) or appearance before the age of 30
First degree relatives (Autosomal Dominant)
PTCH gene mutation
Minor:
Macrocephaly
Childhood medulloblastoma
Lymphomesenteric pleural cyst
Congenital malformations: “Coarse face”, Cleft lip/ Palate, moderate or severe hypertelorism
Skeletal abnormalities: Sprengel deformity, marked pectus deformity, marked syndactyly of
digits.
Radiologic abnormalities: Bridging of the sella turcica, Rib anomalies (Bifid/splayed), Vertebral
anomalies, Flame-shaped lucencies of the hands and feet)
Ovarian fibromas
Ocular abnormalities (cataracts, developmental defects, pigmentary changes of retinal
epithelium)
Although an autosomal dominant disorder with a
high degree of penetrance is the usual mode of
inheritance, BCNS has variable expression making its
diagnosis difficult.2,6 Disease onset and clinical
presentation may vary among patients with different
races.3,4Majority of reported cases involve Caucasians. Its
limited epidemiologic data among Asians especially in the
Philippines hamper early detection or cause frequent
misdiagnosis of the condition.
We present a case of basal cell nevus syndrome
in a 56-year old Filipino female with Fitzpatrick skin type
V, the approach to diagnosis, its clinical features and
management.
CASE REPORT
A 56-year old female sought consult due to a 26-
year history of gradually enlarging multiple
hyperpigmented, non-pruritic, non-tender and non-
friable papules initially on the left cheek and the left ear,
patches on the forehead and pedunculated, slightly
pruritic papules on the neck and trunk with gradual
increased in size and number. The patient manifested a
hyperpigmented ulcerated and friable nodule on the left
forearm, excised by private physician without a follow up
histopathologic exam. The excised nodule recurred two
years prior to this consult. She had not undergone
immunosuppression, photosensitivity, radiation therapy
and persistent ultraviolet light exposure.
The patient had a solitary well defined
hyperpigmented ulcerated friable nodule on the left
cheek with rolled border and multiple hyperpigmented
non-friable, plaques and patches on the forehead and left
ear (Fig 1) and multiple hyperpigmented, some
pedunculated non-friable papules on the neck and trunk.
Palmar pits were also seen (Figure 2). She had coarse
facies, mandibular prognathis, broad nasal bridge and
ptosis. (Figure 1)
Histopathologic examination of the nodules on
the left forearm and left cheek showed nodular and
micronodular basal cell carcinoma (BCC) and the
hyperpigmented patch from the left lateral forehead
showed superficial BCC (Figure 3).
Panoramic radiograph revealed two cystic
structures in the mandible (Figure 4). Chest radiograph
showed osteosclerosis of the ribs and clavicles with
unremarkable cardiopulmonary findings. Plain skull
radiography indicated macrocephaly with intracranial
calcifications and calcification on the flax cerebri.
Craniofacial non-enhanced computed tomography (NECT)
scan revealed dense intracranial calcifications along the
falx cerebri and tentorium cerebelli, hyperostosis of the
J Phil Dermatol Soc · May 2019 · ISSN 2094-201X 43
skull and thickened cranium (Figure 5). The sella turcica
was deep with sellar bridging (Figure 6). Cerebrocerebellar
atrophy with ventricular dilatation was also noted. Chest
NECT scan showed bifid first set of ribs (Figure 10). The
first set of ribs and the scapulae were at the same level.
Wide excision of all nodular basal cell carcinomas
on the left cheek and left forearm was performed.
Electrodessication and curettage were done to remove
the multiple papules smaller than 1 cm on the neck and
trunk. Superficial basal cell carcinomas were treated with
4% 5-flourouracil cream twice daily. The patient was
further advised to take oral acitretin 20mg/day for six
months. Lipid profile and liver enzyme levels were
monitored for the first 2 months and every 2 to 3 months
thereafter.
Figure 1. Solitary well
defined
hyperpigmented
ulcerated friable
nodule on the left
cheek with rolled
border and multiple
hyperpigmented well-
defined and ill-
defined non-friable,
plaques and patches
on the forehead and
on the left ear
44 J Phil Dermatol Soc · May 2019 · ISSN 2094-201X
Figure 2. Palmar pits
Figure 3. Histopathology of the nodular basal cell carcinoma on the left forearm (a), nodular and micronodular basal
cell carcinoma on the left cheek (b)showing large and small aggregates of atypical basaloid cells with peripheral
palisading occupying the dermis with mucinous stroma and focal areas of retraction artifact. Histopathology of the
3a
3b
3a
J Phil Dermatol Soc · May 2019 · ISSN 2094-201X 45
superficial basal cell carcinoma on the forehead (c) showing
Figure 4. Panoramic radiograph (a) and NECT scan (b) showing two cystic structures in the mandible.
Figure 5. Sagittal and axial views of the bone window of Cranial CT showing dense intracranial calcifications along the
falx cerebri and tentorium cerebelli hyperostosis of the skull and thickened cranium.
Figure 6. Sella turcica Bridging
4a
46 J Phil Dermatol Soc · May 2019 · ISSN 2094-201X
Figure 7. Chest NECT scan with reconstruction showing the bifid first set of ribs and the first set of ribs and the scapulae
that are at the same level.
DISCUSSION
It has an estimated prevalence of 1 in 31,000 to
1 in 164,000 without gender predilection. 2, 3 The
prevalence of basal cell nevus syndrome in the Philippines
is currently unknown. Table 2 shows the reported cases of
basal cell nevus syndrome in the country.
The pathogenesis of BCNS involves loss of
function mutations of a tumor suppressor gene, PTCH1,
located on chromosome 9q22.3. 2,3The PTCH protein is a
part of a complex along a transmembrane protein,
Smoothened (SMO). The Hedgehog (HH) protein binds to
the PTCH-SMO receptor complex regulating the sonic
hedgehog (SHH) signaling pathway. The SHH signaling
pathway is a major signal transduction pathway during
embryonic development which usually shuts down after
birth.Unregulated activity of SHH signaling pathway may
lead to tissue overgrowth and tumor induction. Activated
HH signaling caused by mutations in the tumor suppressor
gene, PTCH, and/or the G-protein coupled receptor SMO
promote oncogenic signaling and drives the growth of
multiple basal cell carcinomas. 10
The SUFU gene also encodes a path in the SHH
signaling pathway and is found among BCNS patients
without PTCH1 gene mutation. SUFU mutations were
reported to be associated with milder clinical feature such
as lesser BCC lesions and lack of odontogenic keratocysts
but an increased risk of developing childhood
medulloblastoma. 11
Although no similar cutaneous lesions were
found among the patient’s first-degree relatives, she was
observed to exhibit the same genetic phenotype as her
father presenting with course facial features with
hypertelorism. Her father died of lung carcinoma.
Disease manifestations among patients with
lighter skin types may differ from the those with darker
skin types. Around 70-80% of Caucasians with BCNS
manifest multiple BCCs in their early twenties. A 2012
survey conducted among 157 patients with BCNS in Japan
revealed a mean age of 37.4 years old.12The patient in this
case report started to develop multiple BCCs as early as 30
years old.
Approximately 65 percent of affected persons
have calcification of the falx cerebri.3,4 Other areas of
ectopic calcification include the diaphragma sellae and
tentorium cerebelli which is seen in 60 to 80% and 40% of
the cases, respectively.3, 4 Palmoplantar pits are highly
characteristic of BCNS, occurring in 80 percent of
diagnosed cases, specifically older individuals. They are
asymptomatic nonpalpable shallow depressions, which
results from partial or complete absence of stratum
corneum.3 All of these major features manifested in our
patient.
J Phil Dermatol Soc · May 2019 · ISSN 2094-201X 47
Other features present were macrocephaly,
which is seen in 27-80% of the cases, ophthalmologic
abnormalities (4.5-42%) and bifid ribs (16-26%). A study
on the radiological features of 82 BCNS patients in
Maryland, USA showed that 24% had dilated ventricles
and 10% with cerebral atrophy.4,5 Both findings were
found in the patient.
Surveillance among affected patients includes
baseline brain magnetic resonance imaging, dermatologic
examination every four months or more frequently if new
lesions continue to multiply and biannual panorex until
cyst free for two years. A major concern for patients with
BCNS is the development of multiple BCCs, which may
become invasive, penetrating underlying structures,
especially if located on the face. For non-morpheaform
BCCs that are not located on the canthus, nasolabial fold,
perioral and post auricular areas, excision or
electrodessication with curettage can be done. There is a
95% cure rate if a lesion greater than 2 cm in diameter is
excised with 1.2 cm margin and a recurrence rate of
17.6%.4With curettage and desiccation (C&D), the highest
cure rate (98%) is achieved for lesions less than 1 cm and
84% for lesions greater than 2 cm and is not
recommended for large BCCs. Recurrence rate is
approximately 40%. 4,5
Superficial BCCs can be treated with topical
medications. Imiquimod 5% cream can cause histologic
and clinical clearance rates of 73 to 75% if applied five to
seven times a week. 5-fluorouracil 4% cream treatment
exhibits a 90% histologic clearance rate after 3 weeks and
a 5-year recurrence rate of 21%, whichcan be reduced to
6% if curettage is performed initially. 4,5 Hence, 5-FU was
the treatment option for the patient’s superficial BCCs.
Other treatment options include cryosurgery,
photodynamic therapy and Mohs micrographic surgery,
which is superior among all the other treatment
modalities with a cure rate of as high as 99% and
recurrence rate of 1-5.6%. Radiation therapy can be used
as an adjunct when margins are positive after excision or
for extensive perineural involvement. 4
Second generation retinoids like acitretin were
found to dramatically reduce the development of
premalignant and malignant degeneration of cutaneous
lesion. Hence, the patient was advised to take acitretin at
a dose of 20mg/day for 6 months.13
In general, the prognosis of basal cell nevus
syndrome is excellent. Even recurrent BCCs have
favorable prognosis. Periodic full body examination
should be done to check for new lesions. The patient must
be advised that approximately 40-50% of patients with
primary carcinoma will develop one or more lesions within
5 years. 4,5
CONCLUSION
Basal cell nevus syndrome exists among Filipinos.
Because of a highly variable penetrance, various
phenotypic presentations exist. Since the disease presents
differently among dark-skinned individuals, early
diagnosis poses a challenge among physicians.
Epidemiologic and prevalence studies among Filipinos
may be done to aid in the diagnosis and early
management of this rare genodermatosis.
48 J Phil Dermatol Soc · May 2019 · ISSN 2094-201X
Table 2. Reported cases of Basal cell nevus syndrome 7,8,9
Author/ year
Journal
Gender /age of
diagnosis
Fitzpatrick
skin type
Major criteria
Minor criteria
Chief complaint
History
Management
Magbuhat
et.al. (2017)
Philippine
Journal Of
Otolaryngology-
Head And Neck
Surgery
Female/ 46 yo
V
Multiple BCCs
Calcification of
the falx cerebri
Odontogenic
keratocyst
Multiple
palmar pits
Vertebral
anomalies
(straightened
cervical vertebra
with spurs and
sclerosis on
endplates ,
decreased
intervertebral
space between
C4 and C5)
Necrotic ulcer over
the left orbital
region
10 years prior a
skin-colored, non-
pruritic, non-painful
papilla-like lesion
appeared on her
left upper eyelid
that eventually
became a
hyperpigmented
plaque and
developed non
healing ulcer with
occasional bleeding
and pustular
discharge.
Wide excision of the left
orbital mass with
exenteration,
excision of both paranasal
masses and the alar mass,
left total parotidectomy
with facial nerve
preservation, enucleation
of mandibular cyst, and
cervicofacial
reconstruction with left
orbital split thickness skin
graft and left ala full
thickness skin graft.
Sabido, et.al.
(2013)
Journal of
Philippine
Dermatological
society
Female/11 yo
III
Multiple BCCs
before 30 yo
Multiple
palmar pits
Bilateral ovarian
calcification
multiple discrete,
skin-colored to
speckled brown,
pearly papules on
the face,
clavicular area, and
upper back.
The lesions were
not present at birth,
and appeared a few
years prior to
consult with out
associated
pruritus, bleeding
and pain
Removal of the lesions
using ablative
erbium:YAG laser,
Imiquimod cream
application every other
night
Photoprotection
Ledesma-
Parcia et.al
(2009)
Journal of
Philippine
Dermatological
society
Female/67
V
Multiple BCCs
Odontogenic
keratocyst
Multiple
palmar pits
*
Multiple bluish
black papules,
plaques and tumors
on the face, trunk
and extremities
7 years prior to
consult, the lesions
started to appear
on the face , trunk
and anterior thighs
which gradually
increased in size
and bled with
trauma.
Excision of the large lesions
Electrocautery and
imiquimod cream
application thrice per week
on the smaller lesions
Photoprotection
Regular follow-up every 3
months
J Phil Dermatol Soc · May 2019 · ISSN 2094-201X 49
REFERENCES
1. Evans DG, Oudit D, Smith MJ, Rutkowski D, Allan E, Newman WG, Lear JT. First
evidence of genotype-phenotype correlations in Gorlinsyndrome.J Med
Genet. 2017;54(8):530. Epu b 2017 Jun 8.
2. Castori, M. et.al. Genetic Diseases Predisposing to Basal cell carcino ma.
Review article. Eu ropean Journal of Dermatology. 20 12. Vol 22(3). P299-309
3. Kimonis, VE. et.a l. Clinical Manif estations in 105 Persons with Nevoid Basal
Cell Carcinoma Syndrome. . American Journal of Medical Genetics. 1997.
Vol.69. P299-308
4. Wolff K. et.al. B asal Cell Nevus Syndrome. Fi tzpatrick’s Dermatology in Ge neral
Medicine. 7th edition. 2008. McGraw-Hill Companies. Volume 1: p 1042-48
and 1294-1303
5. Bolognia, J.L., J.L Jorizzo, R.P. Rapini. Dermatology 2nd edition.2008. USA:
Mosby Elsevier. p p 561-73.
6. Reddy, KV. et.al. Diagnosis of Jaw cyst Basal Cell Nevus Syndrome from
Multiple Odonto genic Keratocyst in a 3D CT scan. Case report. Journal of
Indian Academy of Oral Medicine and Radiology. 2011. Vol 23. S401-404
7. Magbuhat DC, Matsuo JM and dela Cruz, RA. Basal Cell Carcinoma,
Odontogenic Cysts, Brain and Skeletal Abnormalities (Gorlin Goltz Syndrome)
in a 46-Year-Old Woman. Philippine Jo urnal Of Otolaryngology-Head And Neck
Surgery Vol. 32 No. 2 JulyDecember 2017. pp38-42
8. Sabido PWE, Jamora MJ, and Encarnacion LE. Multiple basal cell carcinomas
in an 11-yo Filipino-American girl with basal cell nevus syndrome. J Phil
Dermatol Soc. November 2013. pp. 69-73
9. Ledesma-Pacia AG, King-Ismael D, Reyes-Cacas TM, and Tan ED. Basal cell
carcinoma arising from a palmar p it in a Filipino with nevoid basal cell
carcinoma syndrome. J Phil Dermatol Soc. November 2009. Vol 18. no 2. pp
27-31
10. Athar M, Li C, Kim AL, Spiegelman VS, and Bickers DR. Sonic Hedgehog
Signaling in Bas al Cell Nevus Syndrome. Cancer Res. 2014 Sep 15; 74(18):
49674975.
11. Smith MJ, Beetz C, Williams S G, et.al. Germline mutations in SUFU cause
Gorlin syndrome-associated childhood medulloblastoma and redefine the
risk associa ted with PTCH1 muta tions. J Clin Onco l. 2014;32(36):4155. Epub
2014 Nov 17.
12. Endo M, Fujii K, Sugita K, Sai to K, Kohno Y, Miyashita T. Nationwide survey
of nevoid basa l cell carcinoma syndrome in Japan revealing the low
frequency of basal cell carcinoma. Am J Med Genet A. 2012 Feb; 158A(2):
351-7. doi: 10.1002/ajmg.a.3 4421. Epub 2012 Jan 13.
13. Chen K, Craig JC and Shumack S. Oral retinoids for the prevention of skin
cancers in solid organ transplant recipients: a sys tematic review o f
randomized c ontrolled trials. Br J Dermato l. 2005;152(3):518.
50 J Phil Dermatol Soc · May 2019 · ISSN 2094-201X
ResearchGate has not been able to resolve any citations for this publication.
Article
Full-text available
Objective: To present the case of a 46-year-old woman with basal cell carcinoma, odontogenic cysts, brain anomalies and skeletal abnormalities. Method: Design: Case Report Setting: Tertiary National University Hospital Patient: One Results: A 46-year-old woman consulted for a non-healing, necrotic left orbital ulcer that started as a skin-colored, papilla-like lesion on the upper eyelid. There were also hyperpigmented lesions with ill-defined borders over both paranasal areas. Tissue biopsies revealed basal cell carcinoma. Radiologic imaging showed cystic lesions in the mandible, straightening of cervical vertebrae and calcifications of the falx cerebri, tentorium cerebelli, pineal gland and choroid plexus. Based on established major and minor clinical and radiologic criteria, we arrived at a diagnosis of Gorlin Goltz Syndrome or Nevoid Basal Cell Carcinoma Syndrome (NBCCS). She underwent wide excision of the left orbital mass with exenteration, excision of left and right paranasal masses, left total parotidectomy with facial nerve preservation, enucleation of mandibular cyst, and cervicofacial reconstruction with skin grafts of the left orbital area and ala. Conclusion: NBCCS is a rare autosomal dominant disorder with a high tendency for neoplasms and developmental anomalies. Diagnosis can easily be missed if the physician is unaware of its classic but bizarre presentation. Early recognition and prompt specialist referral is very important in order to prevent complications and provide better prognosis. Patients should be reminded of the importance of follow-up as other presentations of the syndrome may manifest later in life, and family genetic screening and counseling should be undertaken. Keywords: Gorlin Goltz Syndrome; Nevoid Basal Cell Carcinoma Syndrome; odontogenic keratocyst
Article
Full-text available
The purpose of this report is to discuss the diagnosis of Jaw cyst basal cell nevus syndrome. Two components of the syndrome are multiple odontogenic keratocysts and basal cell carcinomas. The discovery of multiple keratocysts is usually the first manifestation of the syndrome. In the case discussed, 3D CT scan taken to evaluate a diagnosed odontogenic keratocyst revealed more than one keratocysts. This led to the closer evaluation and diagnosis of Jaw cyst basal cell nevus syndrome.
Article
Full-text available
The hedgehog (Hh) signaling pathway is considered to be a major signal transduction pathway during embryonic development, but it usually shuts down after birth. Aberrant Sonic hedgehog (Shh) activation during adulthood leads to neoplastic growth. Basal cell carcinoma (BCC) of the skin is driven by this pathway. Here, we summarize information related to the pathogenesis of this neoplasm, discuss pathways that crosstalk with Shh signaling, and the importance of the primary cilium in this neoplastic process. The identification of the basic/translational components of Shh signaling has led to the discovery of potential mechanism-driven druggable targets and subsequent clinical trials have confirmed their remarkable efficacy in treating BCCs, particularly in patients with nevoid BCC syndrome (NBCCS), an autosomal dominant disorder in which patients inherit a germline mutation in the tumor-suppressor gene Patched (Ptch). Patients with NBCCS develop dozens to hundreds of BCCs due to derepression of the downstream G-protein-coupled receptor Smoothened (SMO). Ptch mutations permit transposition of SMO to the primary cilium followed by enhanced expression of transcription factors Glis that drive cell proliferation and tumor growth. Clinical trials with the SMO inhibitor, vismodegib, showed remarkable efficacy in patients with NBCCS, which finally led to its FDA approval in 2012. Cancer Res; 74(18); 1-9. ©2014 AACR.
Article
Full-text available
Basal cell carcinoma (BCC) is the commonest cancer in humans. Predisposing factors reflect common genetic variations and environmental influences in most cases. However, an underlying Mendelian disorder should be suspected in a specific subset of patients, namely those with multiple, early onset lesions. Some specific conditions, including Gorlin, Bazex-Dupré-Christol and Rombo syndromes, and Xeroderma Pigmentosum, show BCC as a prominent feature. In addition, BCC may represent a relatively common, although less specific, finding in many other genodermatoses. These include disorders of DNA replication/repair functions (Bloom, Werner, Rothmund-Thomson and Muir-Torre syndromes), genodermatoses affecting the folliculo-sebaceus unit (Brooke-Spiegler, Schöpf-Schulz-Passarge and Cowden syndromes), immune response (cartilage-hair hypoplasia and epidermodysplasia verruciformis) and melanin biosynthesis (oculocutaneous albinism and Hermansky-Pudlak syndrome), and some epidermal nevus syndromes. Further conditions occasionally associated with BCCs exist, but the significance of the association remains to be proven.
Article
Background Gorlin syndrome (GS) is an autosomal dominant syndrome characterised by multiple basal cell carcinomas (BCCs) and an increased risk of jaw cysts and early childhood medulloblastoma. Heterozygous germline variants in PTCH1 and SUFU encoding components of the Sonic hedgehog pathway explain the majority of cases. Here, we aimed to delineate genotype–phenotype correlations in GS. Methods We assessed genetic and phenotypic data for 182 individuals meeting the diagnostic criteria for GS (median age: 47.1; IQR: 31.1–61.1). A total of 126 patients had a heterozygous pathogenic variant, 9 had SUFU pathogenic variants and 46 had no identified mutation. Results Patients with variants were more likely to be diagnosed earlier (p=0.02), have jaw cysts (p=0.002) and have bifid ribs (p=0.003) or any skeletal abnormality (p=0.003) than patients with no identified mutation. Patients with a missense variant in PTCH1 were diagnosed later (p=0.03) and were less likely to develop at least 10 BCCs and jaw cysts than those with other pathogenic PTCH1 variants (p=0.03). Patients with SUFU pathogenic variants were significantly more likely than those with PTCH1 pathogenic variants to develop a medulloblastoma (p=0.009), a meningioma (p=0.02) or an ovarian fibroma (p=0.015), but were less likely to develop a jaw cyst (p=0.0004). Conclusion We propose that the clinical heterogeneity of GS can in part be explained by the underlying or SUFU variant.
Article
Heterozygous germline PTCH1 mutations are causative of Gorlin syndrome (naevoid basal cell carcinoma), but detection rates > 70% have rarely been reported. We aimed to define the causative mutations in individuals with Gorlin syndrome without PTCH1 mutations. We undertook exome sequencing on lymphocyte DNA from four unrelated individuals from families with Gorlin syndrome with no PTCH1 mutations found by Sanger sequencing, multiplex ligation-dependent probe amplification (MLPA), or RNA analysis. A germline heterozygous nonsense mutation in SUFU was identified in one of four exomes. Sanger sequencing of SUFU in 23 additional PTCH1-negative Gorlin syndrome families identified a SUFU mutation in a second family. Copy-number analysis of SUFU by MLPA revealed a large heterozygous deletion in a third family. All three SUFU-positive families fulfilled diagnostic criteria for Gorlin syndrome, although none had odontogenic jaw keratocysts. Each SUFU-positive family included a single case of medulloblastoma, whereas only two (1.7%) of 115 individuals with Gorlin syndrome and a PTCH1 mutation developed medulloblastoma. We demonstrate convincing evidence that SUFU mutations can cause classical Gorlin syndrome. Our study redefines the risk of medulloblastoma in Gorlin syndrome, dependent on the underlying causative gene. Previous reports have found a 5% risk of medulloblastoma in Gorlin syndrome. We found a < 2% risk in PTCH1 mutation-positive individuals, with a risk up to 20× higher in SUFU mutation-positive individuals. Our data suggest childhood brain magnetic resonance imaging surveillance is justified in SUFU-related, but not PTCH1-related, Gorlin syndrome. © 2014 by American Society of Clinical Oncology.
Article
Nevoid basal cell carcinoma syndrome (NBCCS) is characterized by developmental defects and tumorigenesis. The clinical manifestations of NBCCS have been reported in large epidemiological studies from the United States, the United Kingdom, and Australia, but not from an Asian country. We conducted a nationwide survey and identified 311 NBCCS patients in Japan. We investigated the detailed clinical manifestations of 157 patients ranging in age from 9 months to 77 years old (mean: 33.1 years). We then compared the frequency and age of onset for various tumors developed in Japanese NBCCS patients with patients from the three countries listed above in which NBCCS studies were previously conducted. Our most significant finding was the low frequency of basal cell carcinoma (BCC) in Japanese patients. Frequency of BCC in patients over 20 years of age was 51.4%, a much lower rate compared to the United States, Australia, and the United Kingdom (91%, 85%, and 73%, respectively). The mean age of BCC onset was 37.4 years of age, a much older age compared to the above-mentioned countries. These findings suggest that differences in ethnicity and/or environmental factors affect the incidence of BCC. Because the age of BCC onset is generally higher in Japanese NBCCS patients, careful skin examination over a prolonged period of time is warranted.
Article
Nevoid basal cell carcinoma syndrome (NBCC; Gorlin syndrome), an autosomal dominant disorder linked to 9q22.3-q31, and caused by mutations in PTC, the human homologue of the Drosophila patched gene, comprises multiple basal cell carcinomas, keratocysts of the jaw, palmar/plantar pits, spine and rib anomalies and calcification of the falx cerebri. We reviewed the findings on 105 affected individuals examined at the NIH since 1985. The data included 48 males and 57 females ranging in age from 4 months to 87 years. Eighty percent of whites (71/90) and 38% (5/13) of African-Americans had at least one basal cell carcinoma (BCC), with the first tumor occurring at a mean age of 23 (median 20) years and 21 (median 20) years, respectively. Excluding individuals exposed to radiation therapy, the number of BCCs ranged from 1 to > 1,000 (median 8) and 1 to 3 (median 2), respectively, in the 2 groups. Jaw cysts occurred in 78/105 (74%) with the first tumor occurring in 80% by the age of 20 years. The number of total jaw cysts ranged from 1 to 28 (median 3). Palmar pits and plantar pits were seen in 87%. Ovarian fibromas were diagnosed by ultrasound in 9/52 (17%) at a mean age of 30 years. Medulloblastoma occurred in 4 patients at a mean age of 2.3 years. Three patients had cleft lip or palate. Physical findings include "coarse face" in 54%, relative macrocephaly in 50%, hypertelorism in 42%, frontal bossing in 27%, pectus deformity in 13%, and Sprengel deformity in 11%. Important radiological signs included calcification of the falx cerebri in 65%, of the tentorium cerebelli in 20%, bridged sella in 68%, bifid ribs in 26%, hemivertebrae in 15%, fusion of the vertebral bodies in 10%, and flame shaped lucencies of the phalanges, metacarpal, and carpal bones of the hands in 30%. Several traits previously considered components of the syndrome (including short fourth metacarpal, scoliosis, cervical ribs and spina bifida occulta) were not found to be significantly increased in the affected individuals. This study delineates the frequency of the clinical and radiological anomalies in NBCC in a large population of US patients and discusses guidelines for diagnosis and management.
Article
The increased incidence of skin cancers after solid organ transplantation is well recognized. Skin cancers developing in transplant recipients are more aggressive in behaviour. Therapeutic options to reduce and/or delay the development of cutaneous neoplasms are therefore of interest. The objective of this review was to summarize the available medical literature from randomized controlled trials on the use of oral retinoids as a preventive agent for skin cancers in the solid organ transplant population. Three electronic databases were searched for relevant trials: MEDLINE (1966-October 2003), EMBASE (1980-week 44, 2003) and the Cochrane Controlled Trials Register (third quarter 2003). Randomized or quasi-randomized controlled clinical trials on subjects of any age or ethnic background who had received a solid organ transplant (cardiac, renal, liver, etc.) were evaluated. All titles and abstracts found by the search strategy were independently reviewed by two researchers for inclusion into the review. Eighty-one abstracts were identified through the electronic databases for consideration. Review of the abstracts identified three eligible trials. One cross-over trial involving 23 subjects treated with acitretin 25 mg daily for 12 months reported 46 squamous cell carcinomas (SCCs) developing in six subjects during acitretin treatment vs. 65 SCCs developing in 15 subjects during the drug-free period. Another trial involving 44 subjects treated with acitretin 30 mg daily or placebo for 6 months reported two of 19 subjects developing two SCCs in the treatment group vs. nine of 19 subjects developing 18 new skin cancers (15 SCCs, one Bowen's disease, two basal cell carcinomas) in the placebo group. One dose comparison trial involving 26 renal transplant recipients treated with acitretin did not find a significant difference in numbers of skin cancers developing at the doses examined. The major limitation to the use of acitretin was poor tolerance due to adverse events. Headaches, rash, musculoskeletal symptoms and hyperlipidaemia were the most common causes of withdrawal from treatment. No alterations in renal or liver function were detected during the periods of treatment or follow-up. The available data from a small number of randomized controlled trials suggest that acitretin may have a role in the management of solid organ transplant recipients with skin cancers. Tolerability of the drug is a major factor limiting its use. Appropriate selection of patients may help improve the risk-benefit ratio.
Basal Cell Nevus Syndrome. Fitzpatrick's Dermatology in General Medicine
  • K Et Wolff
Wolff K. et.al. Basal Cell Nevus Syndrome. Fitzpatrick's Dermatology in General Medicine. 7th edition. 2008. McGraw-Hill Companies. Volume 1: p 1042-48 and 1294-1303